chr1-15296725-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001391957.1(FHAD1):c.610G>A(p.Glu204Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,551,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001391957.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHAD1 | NM_001391957.1 | c.610G>A | p.Glu204Lys | missense_variant | 5/34 | ENST00000688493.1 | NP_001378886.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHAD1 | ENST00000688493.1 | c.610G>A | p.Glu204Lys | missense_variant | 5/34 | NM_001391957.1 | ENSP00000509124 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000949 AC: 15AN: 158056Hom.: 0 AF XY: 0.000108 AC XY: 9AN XY: 83424
GnomAD4 exome AF: 0.000106 AC: 149AN: 1399836Hom.: 0 Cov.: 31 AF XY: 0.000101 AC XY: 70AN XY: 690396
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | The c.610G>A (p.E204K) alteration is located in exon 5 (coding exon 4) of the FHAD1 gene. This alteration results from a G to A substitution at nucleotide position 610, causing the glutamic acid (E) at amino acid position 204 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at